Background: Late-onset sepsis (LOS) is an important cause of death and neurodevelopmental impairment in premature infants. The purpose of this study was to assess overall incidence of LOS, distribution of LOS-causative organisms and center variation in incidence of LOS for extremely premature infants over time. we compared the incidence of LOS and pathogen distribution in the 2 eras using the χ 2 test. We also examined the effect of birth year on the incidence of LOS using multivariable regression to adjust for nonmodifiable risk factors and for center. To assess whether the incidence of LOS was different among centers in era 2, we used a multivariable regression model to adjust for nonmodifiable risk factors. Results: Ten-thousand one-hundred thirty-one infants were studied. LOS occurred in 2083 of 5031 (41%) infants in era 1 and 1728 of 5100 (34%) infants in era 2 (P < 0.001). Birth year was a significant predictor of LOS on adjusted analysis, with birth years 2000-2009 having a significantly higher odds of LOS than the reference year 2011. Pathogens did not differ, with the exception of decreased fungal infection (P < 0.001). In era 2, 9 centers had significantly higher odds of LOS compared with the center with the lowest incidence. Conclusions: The incidence of LOS decreased over time. Further investigation is warranted to determine which interventions have the greatest impact on infection rates.
L ate-onset sepsis (LOS, occurring after 3 postnatal days) is associated with increased mortality and morbidity among infants hospitalized in the neonatal intensive care unit (NICU). 1 Extremely low birth weight (ELBW) infants are at particularly high risk for infection because of multiple factors including immaturity of the immune system, prolonged hospitalization and frequent invasive procedures such as endotracheal intubation and intravascular catheterization. LOS is associated with poor outcomes, including 18% mortality and prolonged hospital stay. 1 Among surviving ELBW infants, 65% have at least 1 suspected or culture-proven infection episode during their hospitalization after birth, and 35%-37% have culture-proven LOS.
1,2 ELBW infants with LOS, even without meningitis, also have significantly increased rates of neurodevelopmental impairment compared with those not infected. 2 Given the morbidity and mortality associated with LOS, strategies have been implemented in NICUs worldwide to decrease the incidence of infection. Interventions include maternal chemoprophylaxis for prevention of early-onset group B streptococcal infection, rigorous hand hygiene procedures, improved central line care with central line bundles, antifungal prophylaxis and careful attention to NICU design and staffing. [3] [4] [5] [6] [7] [8] [9] [10] Several studies have suggested a decreased incidence of LOS over time, 5, 6, 11 but others have shown a stable to slightly increased incidence. 3, 12, 13 The purpose of this study was to assess the following: (1) the incidence of LOS over time; (2) the distribution of LOS-associated pathogens over time; and (3) center variation in incidence of LOS among extremely
MATERIALS AND METHODS

Subjects
This was a retrospective analysis of a prospective cohort study of infants entered into the Generic Database of the NRN who were born between January 1, 2000, and December 31, 2011, and survived >72 hours after birth. This study period was selected to coincide with NRN funding periods to minimize variability among centers present in the NRN. Data from the 12 centers that participated in the NRN for the entire study period (Brown University, Case Western Reserve University, Cincinnati Children's Hospital Medical Center, Duke University, Emory University, Indiana University, Stanford University, University of Alabama at Birmingham, University of Texas Southwestern Medical Center, University of Texas Health Science Center at Houston, Wayne State University and Yale University) were included. Infants studied had a birth weight of 401-1000 g and gestational age of 22 0/7 to 28 6/7 weeks. Clinical data for these infants were recorded and processed as described previously.
14 The institutional review board at each center approved the NRN Generic Database.
Definitions
To assess trends in LOS over time, data were divided into 2 eras: 2000-2005 (era 1) and 2006-2011 (era 2). The cutoff between eras was selected a priori to achieve an equal length of time for each era (and thus, roughly equal numbers of infants in each group). The primary outcome of the study was LOS. LOS was defined as the first episode of a positive blood culture for a bacterial or fungal organism that was obtained after 72 hours of life. We included positive blood cultures for potential contaminants, such as coagulase-negative staphylococci (CoNS), if the infants were treated with antimicrobials for ≥5 days. 1 As a sensitivity analysis to determine whether this more inclusive definition of LOS could have affected the results, we repeated our primary analysis using a definition of LOS that excluded episodes caused by CoNS and other possible contaminants. Secondary outcomes included death (all-cause mortality) before discharge, death associated with infection before discharge, length of hospital stay (including infants who died) and postmenstrual age at discharge. Death was determined to be associated with infection if the attending physician noted that, based on clinical evidence and autopsy findings, infection was the underlying, proximate disease that initiated the series of events leading to death. There was no specified timing between LOS and death that limited physicians from choosing infection as a contributory cause of death.
We evaluated the distribution of organisms causing the first episode of LOS in our cohort of infants. Because of differences in database entry practices over time (in 2000 and 2001, causative organisms were not assigned to a particular episode of sepsis), we could not identify the causative organism for 189 episodes of LOS occurring in era 1. These episodes were excluded from analysis of organism types but included in the overall analyses.
Statistical Analysis
Assessment of LOS Incidence Over Time
We evaluated the change in LOS over time using 2 methods. First, a direct comparison between eras allowed us to illustrate differences in demographics, pathogens and clinical characteristics that could explain potential differences. We compared the incidence of the primary and secondary outcomes in the 2 eras using the χ 2 test (categorical variables) and the Wilcoxon rank-sum test (continuous variables). We repeated this analysis of secondary outcomes among just infants with LOS and also generated logistic or linear regression models with gestational age as an additional covariate. For our second approach to assess incidence of LOS over time, we performed an additional multivariable regression analysis that included the above covariates (including center) in addition to birth year.
Assessment of Organ Distribution Over Time
We compared the distribution of LOS pathogens between eras 1 and 2 using the χ 2 test.
Assessment of Center Variation
To assess whether the incidence of LOS was different among centers in eras 1 and 2, we used a logistic regression model with center as a fixed effect to adjust for known risk factors including gestational age (using 28 weeks as a reference), birth weight, small for gestational age (SGA), race, sex, antenatal steroids and multiple births. The center with the lowest incidence of LOS in each era was used as the reference center.All P values were 2-tailed and were considered to be significant for values <0.05. Analyses were conducted using SAS 9.3 (SAS Institute, Inc., Cary, NC).
RESULTS
A total of 10,131 infants were included in the study (5031 in era 1 and 5100 in era 2). Overall median birth weight was 760 g (interquartile range: 646-875), and the median gestational age was 25 weeks (24) (25) (26) (27) . Infants in the 2 eras were similar in gestational age, birth weight, SGA status, sex and multiple births (Table 1) . In era 2, a significantly higher proportion of infants were exposed to antenatal steroids and were delivered by cesarean section (P < 0.001). Overall, LOS occurred in 3811 of 10,131 infants (38%). The overall incidence of LOS declined from 41% to 34% between eras 1 and 2 (Table 2 ; P < 0.001). In the longitudinal analysis of incidence of LOS, birth year was a significant predictor of LOS on adjusted analysis, with all birth years 2000-2009 having a significantly higher odds of LOS than the reference year 2011 (Fig. 1) . The difference in incidence of LOS between eras 1 and 2 remained significant even when fungal organisms were excluded (era 1: 38% vs. era 2: 32%; P < 0.001) and when episodes of CoNS and other possible contaminants were excluded (era 1: 24% vs. era 2: 17%; P < 0.001). Among all patients, length of hospital stay was 5 days longer, and infants were discharged at a slightly later postmenstrual age in era 2 when compared with era 1 (P < 0.001). After adjustment for gestational age, these differences remained significant in the overall population, but the differences among the subset of infants with LOS were no longer significant. There was no difference in the overall incidence of death or death associated with infection between the 2 eras. Of the infants with LOS, a higher proportion with Gram-positive organisms died in era 2 [297/1340 (22%)] compared with era 1 [253/1430 (18%); P < 0.01]. There was no difference among organism types in death associated with infection (Table 2 ). In both the eras, a higher proportion of infants with LOS died compared with infants without LOS [era 1: 482/2076 (23%) vs. 549/2940 (19%) without LOS, P < 0.001; era 2: 447/1727 (26%) vs. 579/3367 (17%), P < 0.001].
Among episodes for which organism data were available, 2657 of 3624 (73%) were caused by Gram-positive organisms only, 603 of 3624 (17%) were caused by Gram-negative organisms only, 241 of 3624 (7%) were caused by fungal organisms only and 123 of 3624 (3%) were polymicrobial, with multiple types of organisms (Table 3 ). The proportion of episodes of LOS caused by Gram-positive organisms and Gram-negative organisms did not change between the 2 study periods, but the proportion of episodes caused by fungal organisms was lower in era 2 [111/1728 (6%) vs. 188/1896 (10%); P < 0.001]. The proportion of polymicrobial infections was significantly lower in era 2 when compared with era 1 [44/1728 (2.6%) vs. 79/1896 (4.2%); P = 0.007].
Of the 12 centers, 7 showed a significantly lower incidence of LOS in era 2 when compared with era 1 (Fig. 2A) . On multivariable regression, 9 of 11 centers had significantly higher odds of LOS in era 2 than the reference center, which had the lowest incidence (P < 0.05; Fig. 2B ). Gestational age of 23, 24, 25 and 26 weeks (compared with reference, 28 weeks), birth weight and male sex were significant predictors of LOS (P < 0.05). Multiple birth, SGA, race and exposure to antenatal steroids were not significant covariates in the model. Similar center variation was also noted in era 1, with all centers showing significantly higher odds of LOS than the reference center (data not shown).
DISCUSSION
This study demonstrates a decline in LOS over time among extremely preterm infants cared for at 12 academic centers that participated in the National Institute of Child Health and Human Development NRN over a 12-year period, 2000-2011. A reduced incidence of infection was found in 7 of 12 study centers, with no centers showing significantly higher incidence of LOS in era 2 when compared with era 1. The decrease in LOS associated with increasing birth year remained significant after adjustment for center and other risk factors. The 7% absolute change (17% relative change) in incidence of LOS represents a clinically significant finding and validates the efforts that NICUs across the United 
FIGURE 1. Adjusted odds ratio for LOS by birth year (reference: 2011).
States and other countries have made to reduce infection. The relative decrease in incidence of LOS was even higher (29%) when CoNS and other potential contaminants were excluded. Our findings are consistent with other studies that have suggested a decrease in LOS over time. A single-center study showed an improvement in LOS incidence in premature infants 1 year after relocation of a nursery to a different facility. 5 Another single-center study reported decreased rates of nosocomial infection of 26%-29% in the first 3 years after several catheter care interventions, including improved training and education in addition to implementation of a specialty nursing team for catheter care. 15 Twenty-four NICUs in Ohio instituted a quality improvement collaborative to improve catheter care and demonstrated a 20% reduction in the incidence of LOS over 16 months, 6 while another study of 2 hospitals in Minnesota achieved 50% reduction in nosocomial infection after the institution of quality improvement efforts. 9 Quality improvement interventions were also associated with decreased rates of nosocomial infection between 1994 and 1996 in 6 NICUs in the Vermont Oxford Network, between 2007 and 2013 among 330 NICUs in the Pediatrix Network and between 2004 and 2013 at Yale-New Haven Children's Hospital's NICU. 10, 16, 17 These studies demonstrated that quality improvement interventions can lead to decreased incidence of infection.
Several older studies failed to demonstrate a reduction in LOS over time, suggesting that more recent interventions have been more beneficial. An older report from Yale-New Haven Children's Hospital showed that from 1989 to 2003, the number of LOS episodes increased significantly. 3 Two previous studies from the NRN have evaluated the incidence of LOS in infants <1500 g and <25 weeks of gestational age at birth. 13, 18 The incidence was increased in 2002-2004 (59%) when compared with 1991-2001 (50%). These proportions are both increased from 1991-1994 (45%) and 1995-1998 (44%). The incidence of LOS in the most recent era (2006-2011) of the current study was 38%, which is lower than these previous reports from the NRN. However, it should be noted that the current study represents a slightly different population of infants (those <1000 g and <28 weeks of gestational age at birth). Of note, older NRN studies were performed before the introduction of central line bundles, antibiotic stewardship and antifungal prophylaxis. Lack of antibiotic stewardship (ie, broad-spectrum antibiotics and longer initial empiric antibiotic courses) has been associated with increased risk of sepsis. [19] [20] [21] The most recent NRN Generic Database report confirmed an increased incidence of LOS through 2004 and a decreased incidence from 2005 to 2012, although this report did not quantify center differences or examine pathogens. 16 We found that despite the association of LOS with adverse outcomes in ELBW infants, the decrease in LOS over time was not accompanied by a decrease in mortality or length of hospital stay. The explanation for this finding is unclear. A slightly higher percentage of infants with LOS died in era 2 compared with era 1. While more infants with Gram-positive infections died in era 2, there was no difference in infection-associated death among infants with Gram-positive infections between eras 1 and 2. It is possible that the episodes of LOS prevented in the more recent era would have been milder episodes, and thus, the elimination of these episodes had no impact on overall mortality or length of stay. Infants with Gram-positive infections may also represent a group of infants at higher risk of death with a longer exposure to invasive devices, such as catheters, and the Gram-positive organisms were not the cause of death. In addition, although the difference was not significant, the median gestational age was 1 week lower in era 2 than in era 1, which may account for the lack of impact on mortality and the longer length of stay. When we adjusted for gestational age, there was no significant difference in length of hospital stay or postmenstrual age at discharge among infants with LOS. Multiple previous studies have shown variation in the risk of infection across NICUs. 19, 22 The incidence of LOS in era 2 of our study varied markedly across centers, with a maximum odds ratio of 4.8 compared with the reference center. We elected to use the low incidence center as the reference center rather than comparing all sites with a central tendency because we thought that after risk adjustment, if there were truly no significant differences or potential for a best practice to be identified, no center would be statistically different from the low center. We found that the odds of LOS at 9 of 11 sites to be statistically significantly higher than the reference center after risk adjustment; we believe this strengthens the case that "best practices" could be identified and that LOS may be preventable in many cases. The reason why some centers were able to demonstrate a more robust improvement in infection risk over time remains unclear. We postulate that multiple factors contribute to infection risk at a given center, including hand hygiene policies, differences in central line bundle practices and staff training, antibiotic regimens typically used at a particular center (type and duration), nursery design and staffing, use of antifungal prophylaxis and underlying differences in genetic risk of infection. Previous studies on human milk in low birth weight infants have also shown a dose-related impact on neonatal outcomes. 23, 24 Unfortunately, our study was limited in that our database contains no information about the timing and duration of quality improvement projects. In addition, information across the entire study period about centers' antimicrobial use practices and details about human milk feeding were not available, which represents an additional limitation. Given the growing body of literature on the role of lactoferrin and probiotics in infection prevention, further study is warranted on the effect of varying feeding and medication practices across institutions. 25, 26 The strengths of our study include the large sample size of extremely preterm infants, uniform definitions and data collection over time and ability to observe the incidence of LOS across time and across centers in multiple regions in the United States. Our study was limited by its design in that it was a retrospective analysis of a prospective observational study cohort. Regression models in retrospective cohort studies may omit variables that could influence the outcomes. Because death associated with infection was defined according to clinician diagnosis, this variable could have been subject to reporting bias. In addition, data on some organisms were not available in era 1, which may have affected our analysis of the organism distribution. The number of positive cultures for CoNS in each episode was also not available, and therefore, we relied on a clinical definition for infection that has been used previously within our network. 1 Use of this definition may have overestimated the true incidence of LOS in our cohort. We also did not collect information on one of the most significant risk factors for LOS, the presence of central catheters. Knowledge of a change in the use or duration of central catheters in this population could impact our understanding of the change in incidence of LOS over time. We observed a lower incidence of fungal infections in era 2, but we cannot speculate on the cause for this change, as we did not have data on the use of antifungal prophylaxis at participating centers. We also did not have data regarding the timing of infection prevention processes or programs that may have been associated with the variation in the incidence of LOS across different centers. Finally, although the NRN overall mortality among ELBW infants has been dropping over time, 16 we did not note a difference in death associated with infection.
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